ANAVEX New Website - Untitled Page.png

News, Events and Updates

Search
Anavex Life Sciences Announces Change of Auditor to Grant Thornton LLP
  • Mar 4

Anavex Life Sciences Announces Change of Auditor to Grant Thornton LLP

Anavex Life Sciences to Present at the 11th Annual SVB Leerink Global Healthcare Conference
  • Feb 10

Anavex Life Sciences to Present at the 11th Annual SVB Leerink Global Healthcare Conference

Anavex Life Sciences Provides Business Update & Reports Fiscal 2022 First Quarter Financial Results
  • Feb 9

Anavex Life Sciences Provides Business Update & Reports Fiscal 2022 First Quarter Financial Results

Anavex Life Sciences Provides Supplemental Information on ANAVEX®2-73 AVATAR Phase 3 Trial
  • Feb 4

Anavex Life Sciences Provides Supplemental Information on ANAVEX®2-73 AVATAR Phase 3 Trial

Anavex Life Sciences to Announce Fiscal 2022 First Quarter Financial Results on Wednesday, 2/9/2022
  • Feb 3

Anavex Life Sciences to Announce Fiscal 2022 First Quarter Financial Results on Wednesday, 2/9/2022

ANAVEX®2-73 (Blarcamesine) AVATAR Phase 3 Trial met Primary and Secondary Efficacy Endpoints
  • Feb 1

ANAVEX®2-73 (Blarcamesine) AVATAR Phase 3 Trial met Primary and Secondary Efficacy Endpoints

Anavex Life Sciences Reports Positive Results from Phase 1 Clinical Trial of ANAVEX®3-71
  • Jan 10

Anavex Life Sciences Reports Positive Results from Phase 1 Clinical Trial of ANAVEX®3-71

Anavex Life Sciences Promotes Dr. Kaufmann to CSO and Appoints Dr. Hammond as CMO
  • Jan 6

Anavex Life Sciences Promotes Dr. Kaufmann to CSO and Appoints Dr. Hammond as CMO

Anavex Life Sciences to Present at the H.C. Wainwright Virtual BioConnect 2022 Conference
  • Jan 5

Anavex Life Sciences to Present at the H.C. Wainwright Virtual BioConnect 2022 Conference

Anavex Life Sciences to Present at 40th Annual J.P. Morgan Healthcare Conference
  • Dec 14, 2021

Anavex Life Sciences to Present at 40th Annual J.P. Morgan Healthcare Conference

Anavex Life Sciences to Present at the 4th Annual Evercore ISI HealthCONx Conference
  • Nov 29, 2021

Anavex Life Sciences to Present at the 4th Annual Evercore ISI HealthCONx Conference

1
2
345

Stay Connected

Follow us on social media

  • Twitter
  • LinkedIn
  • Instagram
  • Facebook
Newsroom
Webcast Library
Contact Us
Back to Newsroom

Quick Links

Home

Therapeutic Candidates

Investors

News

Patients & Carers

Contact Us

Resources

About Us

SIGMACEPTOR™ 

Corporate Presentation

Forward-Looking Statements

Legal Notice

Privacy Policy

New Logo white .png

Join our mailing list

Thank you for subscribing!

ANAVEX® is a trademark of Anavex Life Sciences Corp. © 2007-2022. All Rights Reserved.